Current CA-125 thresholds may miss ovarian cancer in racially diverse patients, delaying treatment initiation and contributing to health disparities. Original CA-125 studies were conducted on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback